Fabian Lang - Department of Hematology/Oncology, Goethe-University Hospital Frankfurt

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 68 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Combination of Asciminib with ATP Competing Tyrosine Kinase Inhibitors Might Overcome the Negative Impact of ASXL1 Mutations on Molecular Response in Newly Diagnosed CML Patients

Thomas Ernst, Jenny Rinke,Philipp le Coutre, Martina Crysandt, Tim H. H. Brummendorf,Andreas Burchert,Fabian Lang, Susanne Saussele, Markus Pfirrmann, Thomas Lang,Christian Fabisch, Andreas Hochhaus

Bloodno. Supplement 1 (2024): 1774-1774

引用0浏览0引用

Central Nervous System Relapse after Allogeneic HCT in FLT3-mutated AML

Khouloud Kouidri,Fabian Acker,Rosa Toenges, Saskia Pfaff,Sarah Lindner,Julia Riemann, Marek Werth,Salem Ajib,Fabian Lang,Björn Steffen,Thomas Oellerich,Hubert Serve,Anjali Cremer,Gesine Bug

Annals of hematology (2024)

引用0浏览0WOS引用

Interventional Antibiotic Treatment Replacing Antibiotic Prophylaxis During Allogeneic Hematopoietic Stem Cell Transplantation is Safe and Leads to a Reduction of Antibiotic Administration

Rosa Toenges,Fabian Lang, Rakhshinda Ghaffar,Sarah Lindner,Vera Schlipfenbacher,Julia Riemann,Salem Ajib,Khouloud Kouidri,Anjali Cremer,Bodo Weber,Ngoc Thien Thu Nguyen, Antje Knoch,Janne Vehreschild,Hubert Serve,Gesine Bug

Annals of Hematologypp.1-13, (2024)

引用0浏览0WOS引用

A Multicentre, Randomized Trial in Adults with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia to Assess the Efficacy of Ponatinib Versus Imatinib in Combination with Low-Intensity Chemotherapy, to Compare End of Therapy with Indication for Stem Cell Transplantation Versus Tyrosine Kinase Inhibitor, Blinat..

Fabian Lang,Heike Pfeifer,Monika Brueggemann,Eva Hermann,Hubert Serve,Nicola Goekbuget

Oncology research and treatment (2024)

引用0浏览0WOS引用

Liver Failure after Treatment with Inotuzumab and Polychemotherapy Including PEG-asparaginase in a Patient with Relapsed Philadelphia Chromosome–negative Acute Lymphoblastic Leukemia

Daniel Fischer,Rosa Toenges, Kati Kiil, Sabine Michalik,Axel Thalhammer,Gesine Bug,Nicola Gökbuget,Fabian Lang

ANNALS OF HEMATOLOGYno. 2 (2024): 489-498

引用0浏览0WOS引用

POSTER: CML-487 First-in-Human Phase I Study of ELVN-001, an Oral, Selective BCR::ABL1 Tyrosine Kinase Inhibitor, in Patients With Chronic Myeloid Leukemia Who Failed Prior Tyrosine Kinase Inhibitors

Michael Mauro,Fabian Lang,Dong-Wook Kim,Michael Heinrich,Koji Sasaki,Joe Lyssikatos,Helen Collins,Andreas Hochhaus

Clinical Lymphoma Myeloma and Leukemia（2023）

引用0浏览0引用

P1319: TREATMENT WITH MIDOSTAURIN AND OTHER FLT3 TARGETING INHIBITORS IS ASSOCIATED WITH AN INCREASED RISK OF CARDIOVASCULAR ADVERSE EVENTS IN PATIENTS WITH FLT3 MUTATED AML WHO UNDERWENT ALLOGENEIC HCT

Anjali Cremer,Julius C. Enssle, Saskia Pfaff,Khouloud Kouidri,Fabian Lang,Christian Brandts,Andreas Zeiher,Sebastian Cremer,Björn Steffen,Hubert Serve,Gesine Bug

HemaSphereno. S3 (2023)

引用0浏览0引用

Treatment with Midostaurin and Other FLT3 Targeting Inhibitors is Associated with an Increased Risk of Cardiovascular Adverse Events in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation with FLT3-mutated AML

Anjali Cremer,Julius C. Enssle, Saskia Pfaff,Khouloud Kouidri,Fabian Lang,Christian Brandts,Andreas Zeiher,Sebastian Cremer,Björn Steffen,Hubert Serve,Gesine Bug

ANNALS OF HEMATOLOGYno. 10 (2023): 2903-2908

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn